PEDEvidence

SOURCE-LINKED STUDY SUMMARY

Effects of human growth hormone in men over 60 years old.

The New England journal of medicine ·

Human

Abstract summarized · Quality not appraised
Studied
A controlled study observed older men for six baseline months, then compared growth-hormone treatment with no treatment for six months.
Who / model
21 healthy men aged 61–81 with low IGF-I participated: 12 received growth hormone and nine received no treatment.
Studied dose & schedule
Dose and schedule have not yet been extracted for this summary.
Found
In treated men, lean mass increased 8.8 percent, fat mass decreased 14.4 percent and lumbar-spine bone density increased 1.6 percent. Forearm and upper-femur bone density did not significantly change. Skin thickness increased, but the reported result was not statistically significant. Untreated men had no significant changes in these measures.
Limits
No author-stated limitations or adverse-event results were available in the abstract. The comparator received no treatment; random allocation was not described.

Read summary source ↗ · Prepared 9/22/2026 · AI-assisted, source-based summary

Research findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.

Original publication ↗ · DOI: 10.1056/nejm199007053230101

Explore related compounds

How summaries and evidence labels are prepared

← All study summaries